936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods
    Journal Article

    Handorf, E. A.; Smaldone, M. C.; Movva, S.; Mitra, N.
    Biometrical Journal (2024)

    Fulltext@MSK | Save
  • PDGFRb signaling cooperates with b-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis
    Journal Article

    Hu, J.; Hameed, M. R.; Agaram, N. P.; Whiting, K. A.; Qin, L. X.; Villano, A. M.; O’Connor, R. B.; Rozenberg, J. M.; Cohen, S.; Prendergast, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL) and leiomyosarcoma (LMS)
    Journal Article

    Movva, S.; Matloob, S.; Handorf, E. A.; Choy, E.; Merriam, P.; Flieder, D. B.; Cai, K. Q.; Zhou, Y.; Tetzlaff, E. D.; Pagan, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action
    Review

    Somaiah, N.; Tap, W.
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
    Meeting Abstract

    Chen, T. W. W.; Sanfilippo, R.; Jones, R. L.; Schuetze, S. M.; Sebio Garcia, A.; Alvarez, R. M.; Bui, N.; Ahn, J. H.; Loong, H. H. F.; Yen, C. C.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • High-grade undifferentiated pleomorphic sarcoma masquerading as acquired lymphangioma circumscriptum
    Miscellaneous

    Rambhia, P. H.; D’angelo, S. P.; Shah, P. R.
    SKIN: Journal of Cutaneous Medicine (2023)

    Fulltext@MSK | Save
  • Quality of life and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors: analyses from INVICTUS
    Meeting Abstract

    Bauer, S.; Heinrich, M. C.; George, S.; Zalcberg, J. R.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
    Meeting Abstract

    Jones, R. L.; Sanfilippo, R.; Schuetze, S. M.; Sebio, A.; Alvarez, R. M.; Bui, N.; Wagner, A. J.; Chawla, S. P.; Chen, T. W. W.; Pink, D.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • phase II results from the RINGSIDE phase II/III trial of AL102 for treatment of desmoid tumors
    Meeting Abstract

    Kasper, B.; Gounder, M.; Chugh, R.; Agulnik, M.; Van Tine, B. A.; Andelkovic, V.; Choy, E.; Lewin, J.; Ratan, R.; Gordon, G.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save